Arthur M. Cohen & Associates’s Assembly Biosciences ASMB Stock Holding History

Arthur M. Cohen & Associates’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,625	Closed	-$118K	–	139
2020 Q4	$118K	Hold	1,625	–	–	0.03%	141
2020 Q3	$320K	Hold	1,625	–	–	0.08%	112
2020 Q2	$455K	Hold	1,625	–	–	0.14%	82
2020 Q1	$284K	Hold	1,625	–	–	0.11%	89
2019 Q4	$399K	Hold	1,625	–	–	0.12%	89
2019 Q3	$192	Hold	1,625	–	–	0.05%	123
2019 Q2	$263K	Hold	1,625	–	–	0.09%	103
2019 Q1	$384K	Hold	1,625	–	–	0.14%	84
2018 Q4	$724	Hold	1,625	–	–	0.23%	57
2018 Q3	$724	Hold	1,625	–	–	0.22%	62
2018 Q2	$765K	Hold	1,625	–	–	0.29%	53
2018 Q1	$912K	Hold	1,625	–	–	0.34%	49
2017 Q4	$441	Buy	+1,625	New	+$736K	0.12%	74
2017 Q2	$403K	Buy	+1,625	New	+$458K	0.16%	76
2014 Q3	$681K	Buy	+1,625	New	+$144K	0.32%	60

Other funds holding ASMB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arthur M. Cohen & Associates's ASMB Position: Q1 2021 in Review

Arthur M. Cohen & Associates sold out of Assembly Biosciences (ASMB) in Q1 2021, closing a stake of 1,625 shares — an estimated $118K sold.

Arthur M. Cohen & Associates first reported a position in ASMB in Q3 2014 and held it in 15 quarters. The position peaked at $912K in Q1 2018. 107 funds tracked by Wall St. Rank hold ASMB as of Q1 2021.

Arthur M. Cohen & Associates reported no remaining Assembly Biosciences position as of Q1 2021 after selling out during the quarter.
Arthur M. Cohen & Associates sold 1,625 Assembly Biosciences shares in Q1 2021, an estimated $118K.
Arthur M. Cohen & Associates first reported a position in Assembly Biosciences in Q3 2014 and held it in 15 quarters.
Arthur M. Cohen & Associates's Assembly Biosciences position peaked at $912K in Q1 2018.
107 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2021.

Based on Arthur M. Cohen & Associates's 13F filing for Q1 2021, filed 22 Apr 2021.